Global Multi-omics Market size was valued at USD 2.7 Billion in 2024 and is expected to reach USD 7.6 Billion by 2033, at a CAGR of 15.2% during the forecast period 2024 – 2033.
Multi-omics Market: Overview
Multiomics refers to the integration and analysis of data from multiple omics disciplines, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, to gain a comprehensive understanding of biological systems.
A prominent global trend in Multi-omics involves the integration of multiple -omics disciplines, such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics, to provide a comprehensive understanding of biological systems.
This holistic approach allows researchers to capture intricate interactions and dynamics within cells, tissues, and organisms, leading to deeper insights into health, disease, and personalized medicine. Another significant trend is the advancement of high-throughput technologies and data analytics, enabling the generation and analysis of large-scale Multi-omics datasets.
Moreover, there’s a growing emphasis on Multi-omics in translational research and clinical applications, with efforts directed towards biomarker discovery, disease stratification, and therapeutic development. Overall, the integration of Multi-omics approaches is driving transformative changes in biomedical research, fostering interdisciplinary collaborations, and paving the way for more precise and effective diagnostics and treatments.
By type, the bulk Multi-omics segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. A notable trend in bulk multiomics is the integration of multiple omics data types, such as genomics, transcriptomics, and proteomics, to provide comprehensive insights into biological systems and disease mechanisms.
By platform, the genomics segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. The trend in genomics is increasingly focused on precision medicine, leveraging advancements in technologies like CRISPR gene editing, single-cell sequencing, and AI-driven analytics to personalize healthcare and understand complex genetic diseases.
By application, the oncology segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. In oncology, there’s a notable trend towards precision medicine, leveraging Multi-omics approaches for personalized treatment strategies, immunotherapy advancements, targeted therapies, liquid biopsy diagnostics, and integration of AI for data analysis and decision support.
In North America, a prominent trend in Multi-omics research involves the integration of diverse omics data sets, enabling comprehensive analysis of biological systems and advancing precision medicine and personalized healthcare approaches.
Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 2.7 Billion |
| Projected Market Size in 2033 | USD 7.6 Billion |
| Market Size in 2023 | USD 2.3 Billion |
| CAGR Growth Rate | 15.2% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, Platform, Application and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
CMI has comprehensively analyzed the Global Multiomics market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict in depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Global Multi-omics industry.
The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.
List of the prominent players in the Multi-omics Market:
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Agilent Technologies Inc.
- Qiagen N.V.
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Bruker Corporation
- Waters Corporation
- Danaher Corporation
- Roche Holding AG
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California Inc.
- Eurofins Scientific
- BGI Group
- GenScript Biotech Corporation
- NanoString Technologies Inc.
- Takara Bio Inc.
- GE Healthcare
- Beckman Coulter Inc.
- 10x Genomics Inc.
- Others
The Multi-omics Market is segmented as follows:
By Product & Service
- Products
- Instruments
- Consumables
- Software
- Services
By Type
- Single-cell Multiomics
- Bulk Multiomics
By Platform
- Genomics
- Transcriptomics
- Proteomics
- Metabolomics
- Integrated Omics Platforms
By Application
- Cell Biology
- Oncology
- Neurology
- Immunology
By End-use
- Academic and Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America